These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 30200982)

  • 1. Mapping of the Gastrointestinal Short Form Questionnaire (GSF-Q) into EQ-5D-3L and SF-6D in patients with gastroesophageal reflux disease.
    Monroy M; Ruiz MA; Rejas J; Soto J
    Health Qual Life Outcomes; 2018 Sep; 16(1):177. PubMed ID: 30200982
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparison of utility measurement using EQ-5D and SF-6D preference-based generic instruments in patients with rheumatoid arthritis.
    Salaffi F; Carotti M; Ciapetti A; Gasparini S; Grassi W
    Clin Exp Rheumatol; 2011; 29(4):661-71. PubMed ID: 21813061
    [TBL] [Abstract][Full Text] [Related]  

  • 3. EQ-5D-5L and SF-6D Utility Measures in Symptomatic benign Thyroid Nodules: Acceptability and Psychometric Evaluation.
    Wong CKH; Lang BHH; Yu HMS; Lam CLK
    Patient; 2017 Aug; 10(4):447-454. PubMed ID: 28224296
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mapping the FACT-G cancer-specific quality of life instrument to the EQ-5D and SF-6D.
    Teckle P; McTaggart-Cowan H; Van der Hoek K; Chia S; Melosky B; Gelmon K; Peacock S
    Health Qual Life Outcomes; 2013 Dec; 11():203. PubMed ID: 24289488
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Validation of the GSFQ, a self-administered symptom frequency questionnaire for patients with gastroesophageal reflux disease.
    Paré P; Meyer F; Armstrong D; Pyzyk M; Pericak D; Goeree R
    Can J Gastroenterol; 2003 May; 17(5):307-12. PubMed ID: 12772004
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Responsiveness and minimally important difference of SF-6D and EQ-5D utility scores for the treatment of pelvic organ prolapse.
    Harvie HS; Honeycutt AA; Neuwahl SJ; Barber MD; Richter HE; Visco AG; Sung VW; Shepherd JP; Rogers RG; Jakus-Waldman S; Mazloomdoost D;
    Am J Obstet Gynecol; 2019 Mar; 220(3):265.e1-265.e11. PubMed ID: 30471259
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential Psychometric Properties of EuroQoL 5-Dimension 5-Level and Short-Form 6-Dimension Utility Measures in Low Back Pain.
    Cheung PWH; Wong CKH; Cheung JPY
    Spine (Phila Pa 1976); 2019 Jun; 44(11):E679-E686. PubMed ID: 30475342
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of disease severity on EQ-5D and SF-6D utility discrepancies in chronic heart failure.
    Kontodimopoulos N; Argiriou M; Theakos N; Niakas D
    Eur J Health Econ; 2011 Aug; 12(4):383-91. PubMed ID: 20473544
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Are condition-specific utilities more valid than generic preference-based ones in asthma? Evidence from a study comparing EQ-5D-3L and SF-6D with AQL-5D.
    Kontodimopoulos N; Stamatopoulou E; Brinia A; Talias MA; Ferreira LN
    Expert Rev Pharmacoecon Outcomes Res; 2018 Dec; 18(6):667-675. PubMed ID: 30048194
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An empirical evaluation of the SF-12, SF-6D, EQ-5D and Michigan Hand Outcome Questionnaire in patients with rheumatoid arthritis of the hand.
    Dritsaki M; Petrou S; Williams M; Lamb SE
    Health Qual Life Outcomes; 2017 Jan; 15(1):20. PubMed ID: 28118833
    [TBL] [Abstract][Full Text] [Related]  

  • 11. VALIDATION AND COMPARISON OF EQ-5D-3L AND SF-6D INSTRUMENTS IN A SPANISH PARKINSON´S DISEASE POPULATION SAMPLE.
    Garcia-Gordillo MÁ; Del Pozo-Cruz B; Adsuar JC; Cordero-Ferrera JM; Abellan-Perpiñan JM; Sanchez-Martinez FI
    Nutr Hosp; 2015 Dec; 32(6):2808-21. PubMed ID: 26667738
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of EQ-5D-5L, VAS, and SF-6D in Thai Patients on Peritoneal Dialysis.
    Thaweethamcharoen T; Noparatayaporn P; Sritippayawan S; Aiyasanon N
    Value Health Reg Issues; 2019 May; 18():59-64. PubMed ID: 30502661
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mapping the Positive and Negative Syndrome Scale scores to EQ-5D-5L and SF-6D utility scores in patients with schizophrenia.
    Abdin E; Chong SA; Seow E; Verma S; Tan KB; Subramaniam M
    Qual Life Res; 2019 Jan; 28(1):177-186. PubMed ID: 30382480
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interchangeability of the EQ-5D and the SF-6D, and comparison of their psychometric properties in a spinal postoperative Spanish population.
    Selva-Sevilla C; Ferrara P; Gerónimo-Pardo M
    Eur J Health Econ; 2020 Jun; 21(4):649-662. PubMed ID: 32065301
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Validation and comparison of EuroQoL-5 dimension (EQ-5D) and Short Form-6 dimension (SF-6D) among stable angina patients.
    Wu J; Han Y; Zhao FL; Zhou J; Chen Z; Sun H
    Health Qual Life Outcomes; 2014 Oct; 12():156. PubMed ID: 25343944
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Cultural adaptation to Spanish and validation of the Gastrointestinal Short Form Questionnaire].
    Ruiz Díaz MA; Suárez Parga JM; Pardo Merino A; García Vargas M; Pascual Renedo V
    Gastroenterol Hepatol; 2009 Jan; 32(1):9-21. PubMed ID: 19174094
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison between the EQ-5D-3L and the SF-6D quality of life (QOL) questionnaires in patients with chronic obstructive pulmonary disease (COPD) undergoing lung volume reduction surgery (LVRS).
    Thuppal S; Markwell S; Crabtree T; Hazelrigg S
    Qual Life Res; 2019 Jul; 28(7):1885-1892. PubMed ID: 30707368
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mapping between the Roland Morris Questionnaire and generic preference-based measures.
    Khan KA; Madan J; Petrou S; Lamb SE
    Value Health; 2014 Sep; 17(6):686-95. PubMed ID: 25236992
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mapping utility scores from a disease-specific quality-of-life measure in bariatric surgery patients.
    Sauerland S; Weiner S; Dolezalova K; Angrisani L; Noguera CM; García-Caballero M; Rupprecht F; Immenroth M
    Value Health; 2009; 12(2):364-70. PubMed ID: 20667063
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mapping the cancer-specific EORTC QLQ-C30 to the preference-based EQ-5D, SF-6D, and 15D instruments.
    Kontodimopoulos N; Aletras VH; Paliouras D; Niakas D
    Value Health; 2009; 12(8):1151-7. PubMed ID: 19558372
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.